These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 1421394)

  • 1. Calpain activity in patients with thrombotic thrombocytopenic purpura is associated with platelet microparticles.
    Kelton JG; Warkentin TE; Hayward CP; Murphy WG; Moore JC
    Blood; 1992 Nov; 80(9):2246-51. PubMed ID: 1421394
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Calcium-dependent cysteine protease activity in the sera of patients with thrombotic thrombocytopenic purpura.
    Murphy WG; Moore JC; Kelton JG
    Blood; 1987 Nov; 70(5):1683-7. PubMed ID: 2822176
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Isolation and characterization of cysteine proteinase in thrombotic thrombocytopenic purpura.
    Kelton JG; Moore JC; Warkentin TE; Hayward CP
    Br J Haematol; 1996 May; 93(2):421-6. PubMed ID: 8639442
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Calpain proteolysis of von Willebrand factor enhances its binding to platelet membrane glycoprotein IIb/IIIa: an explanation for platelet aggregation in thrombotic thrombocytopenic purpura.
    Moore JC; Murphy WG; Kelton JG
    Br J Haematol; 1990 Apr; 74(4):457-64. PubMed ID: 2346725
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Calpain activity in bone marrow transplant-associated thrombotic thrombocytopenic purpura.
    Zeigler ZR; Kelton JG; Moore JC; Shadduck RK; Andrews DF; Nath R; Agha M
    Bone Marrow Transplant; 1999 Sep; 24(6):641-5. PubMed ID: 10490730
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proteolytic degradation of high molecular weight kininogen in acute thrombotic thrombocytopenic purpura.
    Pavord S; Kelton JG; Warner MN; Moore JC; Warkentin TE; Hayward CP
    Br J Haematol; 1997 Jun; 97(4):762-7. PubMed ID: 9217174
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Studies investigating platelet aggregation and release initiated by sera from patients with thrombotic thrombocytopenic purpura.
    Kelton JG; Moore JC; Murphy WG
    Blood; 1987 Mar; 69(3):924-8. PubMed ID: 3493046
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aetiology and pathogenesis of thrombotic thrombocytopenic purpura and haemolytic uraemic syndrome: the role of von Willebrand factor-cleaving protease.
    Furlan M; Lämmle B
    Best Pract Res Clin Haematol; 2001 Jun; 14(2):437-54. PubMed ID: 11686108
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of Plasma Platelet Microparticles in Thrombotic Thrombocytopenic Purpura.
    Tahmasbi L; Karimi M; Kafiabadi SA; Nikougoftar M; Haghpanah S; Ranjbaran R; Moghadam M
    Ann Clin Lab Sci; 2017 Jan; 47(1):62-67. PubMed ID: 28249919
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elevated endothelial microparticles in thrombotic thrombocytopenic purpura: findings from brain and renal microvascular cell culture and patients with active disease.
    Jimenez JJ; Jy W; Mauro LM; Horstman LL; Ahn YS
    Br J Haematol; 2001 Jan; 112(1):81-90. PubMed ID: 11167788
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Further characterization of platelet-aggregating cysteine proteinase activity in thrombotic thrombocytopenic purpura.
    Consonni R; Falanga A; Barbui T
    Br J Haematol; 1994 Jun; 87(2):321-4. PubMed ID: 7947274
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thrombotic thrombocytopenic purpura plasma enhances platelet-leucocyte interaction in vitro.
    Valant PA; Jy W; Horstman LL; Mao WW; Ahn YS
    Br J Haematol; 1998 Jan; 100(1):24-32. PubMed ID: 9450786
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acquired deficiency of von Willebrand factor-cleaving protease in a patient with thrombotic thrombocytopenic purpura.
    Furlan M; Robles R; Solenthaler M; Lämmle B
    Blood; 1998 Apr; 91(8):2839-46. PubMed ID: 9531594
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibodies to von Willebrand factor-cleaving protease in acute thrombotic thrombocytopenic purpura.
    Tsai HM; Lian EC
    N Engl J Med; 1998 Nov; 339(22):1585-94. PubMed ID: 9828246
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-CD36 antibodies in thrombotic thrombocytopenic purpura.
    Tandon NN; Rock G; Jamieson GA
    Br J Haematol; 1994 Dec; 88(4):816-25. PubMed ID: 7529543
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Minimal evidence of platelet and endothelial cell reactive antibodies in thrombotic thrombocytopenic purpura.
    Raife TJ; Atkinson B; Aster RH; McFarland JG; Gottschall JL
    Am J Hematol; 1999 Oct; 62(2):82-7. PubMed ID: 10509001
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel platelet-agglutinating protein from a thrombotic thrombocytopenic purpura plasma.
    Siddiqui FA; Lian EC
    J Clin Invest; 1985 Oct; 76(4):1330-7. PubMed ID: 3932464
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibody inhibitors to von Willebrand factor metalloproteinase and increased binding of von Willebrand factor to platelets in ticlopidine-associated thrombotic thrombocytopenic purpura.
    Tsai HM; Rice L; Sarode R; Chow TW; Moake JL
    Ann Intern Med; 2000 May; 132(10):794-9. PubMed ID: 10819702
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pathologic effects of plasma from patients with thrombotic thrombocytopenic purpura on platelets and cultured vascular endothelial cells.
    Burns ER; Zucker-Franklin D
    Blood; 1982 Oct; 60(4):1030-7. PubMed ID: 7052160
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elevated plasma neutrophil elastase concentration is associated with disease activity in patients with thrombotic thrombocytopenic purpura.
    Mikes B; Sinkovits G; Farkas P; Csuka D; Schlammadinger A; Rázsó K; Demeter J; Domján G; Réti M; Prohászka Z
    Thromb Res; 2014 Apr; 133(4):616-21. PubMed ID: 24548690
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.